Journal ArticleOPEN ACCESS

Subcutaneous C1-Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1-INH-HAE

Clinical Case Reports (2021) 9(3) 1273-1275
DOI: 10.1002/ccr3.3743
7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Subcutaneous plasma-derived human C1-Inhibitor concentrate (pdC1INH) may be safe and effective for long-term prophylaxis during pregnancy and lactation in hereditary angioedema patients.

Author supplied keywords

Cite

CITATION STYLE

APA

Andarawewa, S., & Aygören-Pürsün, E. (2021). Subcutaneous C1-Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1-INH-HAE. Clinical Case Reports, 9(3), 1273–1275. https://doi.org/10.1002/ccr3.3743

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free